SCHEMBL7246372

SCHEMBL7246372

CN(Cc1cccnc1)C(=O)c1ccc2c(c1)nc(CCc1ccc(C#N)cc1)n2C

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 6/20 0.51
F2 P00734 1/20 0.46
ACACB O00763 1/20 0.45
NSD2 O96028 1/20 0.42
ITK Q08881 1/20 0.42
RAB9A P51151 1/20 0.42
NAMPT P43490 1/20 0.41
MAPT P10636 1/20 0.40
TLR8 Q9NR97 1/20 0.40
TLR7 Q9NYK1 1/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC8 Q9BY41 1/20 0.40
PDK2 Q15119 3/20 0.39
PDK3 Q15120 3/20 0.39
PDK4 Q16654 3/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7247840 0.90 NSD2 (0.52) PDK1F2NSD2ITKRAB9A
SCHEMBL7249769 0.88 HSD17B10 (0.47) PDK1F2ITKMAPTLMNA
SCHEMBL7247078 0.87 F2 (0.51) PDK1F2ITKHDAC1HDAC6
Hydrochloric Acid SCHEMBL7245594 0.86 F2 (0.61) F2RAB9ANAMPT
SCHEMBL7249869 0.86 F2 (0.49) PDK1F2NSD2ITKHDAC1
SCHEMBL7244016 0.83 F2 (0.49) F2NSD2ITKHDAC1HDAC8
SCHEMBL7244700 0.82 F2 (0.48) F2NSD2ITKHDAC1HDAC8
SCHEMBL7245070 0.79 F2 (0.53) F2HDAC1HDAC8HDAC6
SCHEMBL8028362 0.79 ITK (0.50) PDK1F2ITKHDAC1HDAC6
SCHEMBL6486632 0.79 F2 (0.50) F2ITKRAB9AMAPTHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 US disclosed